Amoéba
Develops natural microbiological solutions to manage bacterial and fungal risks.
ALMIB | PA
Overview
Corporate Details
- ISIN(s):
- FR0011051598 (+2 more)
- LEI:
- 9695005QNE7C8Z0LXU64
- Country:
- France
- Address:
- 38 AVENUE DES FRERES MONTGOLFIER, 69680 CHASSIEU
- Website:
- https://amoeba-nature.com/en/
- Sector:
- Manufacturing
- Industry:
- Manufacture of other chemical products
Description
Amoéba is a biotechnology company that develops natural microbiological solutions for managing bacterial and fungal risks. The company's core technology is based on the patented use of the amoeba *Willaertia magna* C2c Maky and its biocidal properties. Its primary focus is on agricultural biocontrol, offering a biofungicide derived from a mechanically lysed amoeba. This product targets plant diseases such as mildews, rusts, and powdery mildew, providing a biological alternative to chemical treatments. Amoéba has also developed applications for its technology in the treatment of bacterial risk in industrial water systems, on surfaces, and for chronic wounds.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Type / Size | Actions | |
|---|---|---|---|---|---|
| 2020-10-06 17:45 |
Press Release - AMOEBA announces the issuance of the seventh tranche of 26 bond…
|
English | PDF • 310.2 KB | ||
| 2020-10-01 18:00 |
AMOEBA DEPOSE LA DEMANDE D’AUTORISATION DE SA SOLUTION DE BIOCONTROLE AUX ETATS…
|
French | PDF • 240.8 KB | ||
| 2020-10-01 18:00 |
AMOEBA FILES THE APPLICATION FOR THE AUTHORIZATION OF ITS BIOCONTROL SOLUTION I…
|
English | PDF • 214.0 KB | ||
| 2020-09-25 17:45 |
AMOEBA : communiqué de mise a disposition du Rapport financier semestriel 2020
|
French | PDF • 322.0 KB | ||
| 2020-09-25 17:45 |
AMOEBA: press release on the availability of the Interim Financial Report for 2…
|
English | PDF • 215.6 KB | ||
| 2020-09-25 17:45 |
AMOEBA : Rapport Financier Semestriel au 30 juin2020
|
French | PDF • 1.1 MB | ||
| 2020-09-24 17:45 |
AMOEBA annonce des résultats semestriels en ligne avec ceux de 2019 et poursuit…
|
French | PDF • 469.8 KB | ||
| 2020-09-24 17:45 |
AMOEBA announces half-year results in line with those of 2019 and continues to…
|
English | PDF • 340.8 KB | ||
| 2020-09-10 08:45 |
AMOEBA : Transfert de cotation des actions de la Société Amoéba sur le marché E…
|
French | PDF • 317.3 KB | ||
| 2020-09-10 08:45 |
AMOEBA: Transfer of Amoéba's shares to the Euronext Growth Paris market
|
English | PDF • 201.3 KB | ||
| 2020-09-04 17:45 |
AMOEBA annonce l’émission de la sixième tranche de 26 obligations convertibles …
|
French | PDF • 280.9 KB | ||
| 2020-09-04 17:45 |
AMOEBA announces the issuance of the sixth tranche of 26 bonds convertible into…
|
English | PDF • 233.4 KB | ||
| 2020-09-03 17:45 |
AMOEBA : Déclaration du nombre total de droits de vote et du nombre d’actions c…
|
French | PDF • 158.9 KB | ||
| 2020-08-11 17:45 |
AMOEBA publie un premier article scientifique concernant son application biocon…
|
French | PDF • 166.8 KB | ||
| 2020-08-11 17:45 |
AMOEBA publishes a first scientific article concerning its biocontrol applicati…
|
English | PDF • 142.8 KB |
Automate Your Workflow. Get a real-time feed of all Amoéba filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Amoéba
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Amoéba via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2024-08-30 | N/A | Other | Buy | 6,300 | 3,609.90 EUR |
| 2024-08-29 | N/A | Other | Sell | 5,500 | 3,564.00 EUR |
| 2024-08-28 | N/A | Other | Buy | 3,200 | 1,782.08 EUR |
| 2024-08-27 | N/A | Other | Buy | 20,049 | 11,231.45 EUR |
| 2024-08-26 | N/A | Other | Buy | 31,107 | 17,441.69 EUR |
| 2024-08-22 | N/A | Other | Buy | 2,255 | 1,298.88 EUR |
| 2024-08-20 | N/A | Other | Buy | 16,664 | 8,838.59 EUR |
| 2024-08-19 | N/A | Other | Buy | 13,390 | 6,795.43 EUR |
| 2024-08-16 | N/A | Other | Buy | 6,745 | 3,468.28 EUR |
| 2024-08-09 | N/A | Other | Buy | 40,748 | 21,559.77 EUR |
Peer Companies
